Superdrug owner considers delaying £1.5bn London IPO until 2027

Superdrug owner AS Watson reportedly considered delaying its £1.5 billion London flotation until 2027, amid potential regulatory complications in Asia. The Hong Kong-based health and beauty group had been preparing a dual listing in London and Hong Kong this autumn. However, regulatory and other complications in Asia meant the initial public offering could be pushed...